Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy Withdrawal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07314346
What this trial is testing

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

Who this might be right for
Healthy Volunteer Study
Atea Pharmaceuticals, Inc. 32
Large-scale testing (Phase 3)Ended earlyNCT04759703
What this trial is testing

Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD

Who this might be right for
Sleep DisorderRestless Legs SyndromeOpioid-use Disorder+1 more
Massachusetts General Hospital 75
Post-approval studies (Phase 4)UnknownNCT01287715
What this trial is testing

Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Erasmus Medical Center 50
Large-scale testing (Phase 3)Looking for participantsNCT06711887
What this trial is testing

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 348
Testing effectiveness (Phase 2)Ended earlyNCT04070157
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal

Who this might be right for
Opioid Withdrawal (Disorder)
USWM, LLC (dba US WorldMeds) 4
Post-approval studies (Phase 4)UnknownNCT00363701
What this trial is testing

Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice

Who this might be right for
DyspepsiaGastroesophageal RefluxdiseaseUlcer
Glostrup University Hospital, Copenhagen 150
Post-approval studies (Phase 4)UnknownNCT01329406
What this trial is testing

Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis

Who this might be right for
Osteoarthritis
Analgesic Solutions 50
Large-scale testing (Phase 3)Study completedNCT02328482
What this trial is testing

Continuation Protocol to Protocol BBCO-001

Who this might be right for
Muscular Dystrophy, Oculopharyngeal (OPMD)
Bioblast Pharma Ltd. 9
Early research (Phase 1)Study completedNCT00056355
What this trial is testing

Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease

Who this might be right for
Crohn Disease
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT04470050
What this trial is testing

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Who this might be right for
Opioid Withdrawal
BioXcel Therapeutics Inc 225
Testing effectiveness (Phase 2)Study completedNCT00011297
What this trial is testing

Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal

Who this might be right for
Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 160
Testing effectiveness (Phase 2)Study completedNCT00974376
What this trial is testing

Gabapentin Treatment of Cannabis Dependence

Who this might be right for
Cannabis DependenceCannabis WithdrawalCognitive Deficits
The Scripps Research Institute 150
Not applicableStudy completedNCT06414616
What this trial is testing

Real-World Evidence of Adherence to Denosumab Therapy and Fracture Risk Associated With Drug Withdrawal: A Cross-sectional Study

Who this might be right for
Osteoporosis
Trakya University 210
Large-scale testing (Phase 3)Looking for participantsNCT07484217
What this trial is testing

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Who this might be right for
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Axsome Therapeutics, Inc. 508
Testing effectiveness (Phase 2)UnknownNCT04234191
What this trial is testing

Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Who this might be right for
Opioid Use Disorder
University of British Columbia 50
Testing effectiveness (Phase 2)WithdrawnNCT00375596
What this trial is testing

The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Bausch & Lomb Incorporated
Large-scale testing (Phase 3)Ended earlyNCT00505414
What this trial is testing

Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

Who this might be right for
PainNeoplasmCancer
Grünenthal GmbH 136
Not applicableUnknownNCT04997330
What this trial is testing

Evaluation of Bilateral HF-rTMS on Abstinence in Alcohol Use Disorder Patients With Executive Dysfunction

Who this might be right for
Alcohol Withdrawal
Assistance Publique - Hôpitaux de Paris 95
Post-approval studies (Phase 4)UnknownNCT06254001
What this trial is testing

Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects

Who this might be right for
Tobacco SmokingTobacco WithdrawalNicotine Addiction+2 more
National Institute of Respiratory Diseases, Mexico 134
Large-scale testing (Phase 3)Study completedNCT01435928
What this trial is testing

PEARL Schizophrenia Maintenance

Who this might be right for
Schizophrenia
Sumitomo Pharma America, Inc. 676
Next Page